Enhancing bioavailability formulations containing soluble acidic drugs
09 March 2023
Research has revealed efficiency of a multi-compartmental dissolution method used to predict in vivo performance of BCS Class IIa compounds.
Doctors see pharma reputation as top priority when picking prescription meds
07 March 2023
A pharma company’s reputation ranked as a leading factor in physician prescription decisions, according to a recent WE Communications Brands survey published in the "Brands in Motion" global report.
Combination therapy significantly improves pulmonary hemodynamics
07 March 2023
Janssen’s single tablet of macitentan plus tadalafil significantly improved pulmonary hemodynamics in a Phase III trial for pulmonary arterial hypertension (PAH).
Murashko: “There is no shortage of drugs in pharmacies”
07 March 2023
There is no shortage of medicines in Russian pharmacies at the moment, as the supply chains have adapted to the current situation, Health Minister Mikhail Murashko told reporters. According to the head of the Ministry of Health of the Russian Federation, the supply chains have adapted to the current situation.
06 March 2023
The Ministry of Health of the Russian Federation has developed a draft law on amendments to Article 69 of the Federal Law “On Fundamentals of the Protection of Citizen’s Health in the Russian Federation”. The bill provides for the possibility of admitting second-year residents to medical practice as trainee doctors. The position of a trainee doctor is provided for by the nomenclature of positions of medical and pharmaceutical workers approved by the Ministry of Health of Russia.
06 March 2023
The Government is launching a special program of preferential lending to companies implementing investment projects for priority industrial products manufacturing. The order on the allocation of the funds and the resolution on the details of the new program were signed by Prime Minister Mikhail Mishustin.
Cell therapy first for chronic heart failure
03 March 2023
In a Phase III trial, a new cell therapy has shown potential for the first time to treat inflammation, a major contributor to heart failure.
Overburdened oncologists: How pharma marketers can thrive by taming the data deluge
03 March 2023
Pharma is becoming a victim of its own success in oncology. Striving to keep pace with the progress of the industry’s well-stocked pipeline, oncologists are facing information overload on top of the continued fallout of the COVID-19 pandemic. The pressures are creating a need for new marketing strategies.
New purification method could enhance protein drug manufacturing
02 March 2023
Bioconjugate-functionalised nanoparticles can isolate proteins from a bioreactor fast and inexpensively, MIT researchers have found.
Identifying bacterial isolates to help prevent cleanroom contamination
02 March 2023
A paper has found that nearly 70 percent of bacterial isolates identified in a study were attributed to operator contamination within a cleanroom facility.
NovaMedica will produce migraine drug Relonova in Moscow
23 March 2023
A resource for anti-tumor drugs testing has been launched in Russia
23 March 2023
Building a Community of Trust in Epilepsy & Rare Syndromes
23 March 2023
22 March 2023